Drug Resistance in Children with Relapsed Acute Lymphoblastic Leukaemia
Author Information
Author(s): R. Pieters, T. Hongo, A.H. Loonen, D.R. Huismans, H.J. Broxterman, K. Hahlen, A.J.P. Veerman
Primary Institution: Free University Hospital, Amsterdam, The Netherlands
Hypothesis
What are the different types of drug resistance in children with relapsed acute lymphoblastic leukaemia?
Conclusion
Children with relapsed acute lymphoblastic leukaemia show varying types of drug resistance that are not primarily due to P-glycoprotein mediated mechanisms.
Supporting Evidence
- Relapsed patients were significantly more resistant to several drugs compared to untreated patients.
- P-glycoprotein was not detected in any of the samples tested.
- Resistance modifiers did not enhance the cytotoxicity of certain drugs.
- Different types of drug resistance were observed among individual patients.
Takeaway
Some kids with leukemia don't respond to certain medicines because their cancer cells have learned to resist them, making treatment harder.
Methodology
The study assessed drug resistance profiles using the MTT assay on leukaemic cells from children with relapsed ALL.
Potential Biases
Potential bias due to the exclusion of B-cell ALL patients and reliance on in vitro assays.
Limitations
The study had a small sample size and may not represent all cases of relapsed ALL.
Participant Demographics
Children with relapsed acute lymphoblastic leukaemia.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website